Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer

Core Insights - Rani Therapeutics has promoted Alireza Javadi, Ph.D., to Chief Technical Officer, marking a significant leadership change as the company advances its pipeline and collaborations [2] Company Overview - Rani Therapeutics is a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, aiming to replace subcutaneous injections or intravenous infusions with oral dosing through its proprietary RaniPill capsule technology [3] - The company has successfully conducted several preclinical and clinical studies to evaluate the safety, tolerability, and bioavailability of its RaniPill capsule technology [3] Leadership and Experience - Alireza Javadi previously served as Vice President of Technical Operations, overseeing Rani's R&D, manufacturing, and automation teams, and will now also be responsible for quality assurance in his new role [2] - His background includes five years as Director of Operations at Cretex Medical and various engineering and scientific roles, including Tooling and Engineering Manager at JunoPacific and Principal Scientist at the Wisconsin Institute for Discovery [2]